Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1471-2407-10-433.

Title:
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models | BMC Cancer
Description:
Background Increased concentrations of choline-containing compounds are frequently observed in breast carcinomas, and may serve as biomarkers for both diagnostic and treatment monitoring purposes. However, underlying mechanisms for the abnormal choline metabolism are poorly understood. Methods The concentrations of choline-derived metabolites were determined in xenografted primary human breast carcinomas, representing basal-like and luminal-like subtypes. Quantification of metabolites in fresh frozen tissue was performed using high-resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS). The expression of genes involved in phosphatidylcholine (PtdCho) metabolism was retrieved from whole genome expression microarray analyses. The metabolite profiles from xenografts were compared with profiles from human breast cancer, sampled from patients with estrogen/progesterone receptor positive (ER+/PgR+) or triple negative (ER-/PgR-/HER2-) breast cancer. Results In basal-like xenografts, glycerophosphocholine (GPC) concentrations were higher than phosphocholine (PCho) concentrations, whereas this pattern was reversed in luminal-like xenografts. These differences may be explained by lower choline kinase (CHKA, CHKB) expression as well as higher PtdCho degradation mediated by higher expression of phospholipase A2 group 4A (PLA2G4A) and phospholipase B1 (PLB1) in the basal-like model. The glycine concentration was higher in the basal-like model. Although glycine could be derived from energy metabolism pathways, the gene expression data suggested a metabolic shift from PtdCho synthesis to glycine formation in basal-like xenografts. In agreement with results from the xenograft models, tissue samples from triple negative breast carcinomas had higher GPC/PCho ratio than samples from ER+/PgR+ carcinomas, suggesting that the choline metabolism in the experimental models is representative for luminal-like and basal-like human breast cancer. Conclusions The differences in choline metabolite concentrations corresponded well with differences in gene expression, demonstrating distinct metabolic profiles in the xenograft models representing basal-like and luminal-like breast cancer. The same characteristics of choline metabolite profiles were also observed in patient material from ER+/PgR+ and triple-negative breast cancer, suggesting that the xenografts are relevant model systems for studies of choline metabolism in luminal-like and basal-like breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

breast, choline, cancer, expression, basallike, models, tissue, pubmed, xenograft, samples, mas, article, gene, google, scholar, concentrations, metabolism, model, luminallike, human, higher, genes, metabolite, data, mrs, cas, significantly, gpc, pcho, xenografts, tumor, differences, glycine, subtypes, concentration, ptdcho, expressed, metabolic, triple, negative, molecular, analysis, studies, profiles, erpgr, lower, spectra, figure, microarray, cells,

Topics {✒️}

spin-echo carr-purcell-meiboom-gill sequence anne-lise børresen-dale full size image reduced choline-ether-phospholipid synthesis beathe sitter & ingrid triple-negative breast cancer triple-negative breast carcinomas choline metabolite profile beathe sitter article download pdf full access glycolysis-related gene signature fine-needle biopsy specimens author information authors spin-echo sequence er+/pgr+ breast cancer estrogen/progesterone receptor positive magnetic resonance spectroscopy pulse-acquired experiment including hr mas mrs color microarray-based platform differentially expressed genes triple negative tissue triple-negative phenotype pre-publication history distinct disease entities magn reson med triple negative samples canonical glycerophospholipid metabolism morse dl privacy choices/manage cookies exp biol med ramirez de ma mammary epithelial cells view hormone receptor status effective echo time metabolite profiles demonstrated breast cancer cells human breast cancer higher gpc/pcho ratio health research ethics choline metabolite profiles breast cancer tissue nat rev cancer breast cancer corresponded breast cancer classification modelling breast cancer implanted breast cancer energy metabolism pathways

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
         description:Increased concentrations of choline-containing compounds are frequently observed in breast carcinomas, and may serve as biomarkers for both diagnostic and treatment monitoring purposes. However, underlying mechanisms for the abnormal choline metabolism are poorly understood. The concentrations of choline-derived metabolites were determined in xenografted primary human breast carcinomas, representing basal-like and luminal-like subtypes. Quantification of metabolites in fresh frozen tissue was performed using high-resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS). The expression of genes involved in phosphatidylcholine (PtdCho) metabolism was retrieved from whole genome expression microarray analyses. The metabolite profiles from xenografts were compared with profiles from human breast cancer, sampled from patients with estrogen/progesterone receptor positive (ER+/PgR+) or triple negative (ER-/PgR-/HER2-) breast cancer. In basal-like xenografts, glycerophosphocholine (GPC) concentrations were higher than phosphocholine (PCho) concentrations, whereas this pattern was reversed in luminal-like xenografts. These differences may be explained by lower choline kinase (CHKA, CHKB) expression as well as higher PtdCho degradation mediated by higher expression of phospholipase A2 group 4A (PLA2G4A) and phospholipase B1 (PLB1) in the basal-like model. The glycine concentration was higher in the basal-like model. Although glycine could be derived from energy metabolism pathways, the gene expression data suggested a metabolic shift from PtdCho synthesis to glycine formation in basal-like xenografts. In agreement with results from the xenograft models, tissue samples from triple negative breast carcinomas had higher GPC/PCho ratio than samples from ER+/PgR+ carcinomas, suggesting that the choline metabolism in the experimental models is representative for luminal-like and basal-like human breast cancer. The differences in choline metabolite concentrations corresponded well with differences in gene expression, demonstrating distinct metabolic profiles in the xenograft models representing basal-like and luminal-like breast cancer. The same characteristics of choline metabolite profiles were also observed in patient material from ER+/PgR+ and triple-negative breast cancer, suggesting that the xenografts are relevant model systems for studies of choline metabolism in luminal-like and basal-like breast cancer.
         datePublished:2010-08-17T00:00:00Z
         dateModified:2010-08-17T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2407-10-433
         keywords:
            Breast Cancer
            Choline
            Xenograft Model
            Triple Negative Breast Cancer
            Solute Carrier Family
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig3_HTML.jpg
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Siver A Moestue
               affiliation:
                     name:Norwegian University of Science and Technology (NTNU)
                     address:
                        name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Eldrid Borgan
               affiliation:
                     name:Norwegian University of Science and Technology (NTNU)
                     address:
                        name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                        type:PostalAddress
                     type:Organization
                     name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Else M Huuse
               affiliation:
                     name:Norwegian University of Science and Technology (NTNU)
                     address:
                        name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Evita M Lindholm
               affiliation:
                     name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Beathe Sitter
               affiliation:
                     name:Norwegian University of Science and Technology (NTNU)
                     address:
                        name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anne-Lise Børresen-Dale
               affiliation:
                     name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Oslo
                     address:
                        name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olav Engebraaten
               affiliation:
                     name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Oslo
                     address:
                        name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gunhild M Mælandsmo
               affiliation:
                     name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ingrid S Gribbestad
               affiliation:
                     name:Norwegian University of Science and Technology (NTNU)
                     address:
                        name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
      description:Increased concentrations of choline-containing compounds are frequently observed in breast carcinomas, and may serve as biomarkers for both diagnostic and treatment monitoring purposes. However, underlying mechanisms for the abnormal choline metabolism are poorly understood. The concentrations of choline-derived metabolites were determined in xenografted primary human breast carcinomas, representing basal-like and luminal-like subtypes. Quantification of metabolites in fresh frozen tissue was performed using high-resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS). The expression of genes involved in phosphatidylcholine (PtdCho) metabolism was retrieved from whole genome expression microarray analyses. The metabolite profiles from xenografts were compared with profiles from human breast cancer, sampled from patients with estrogen/progesterone receptor positive (ER+/PgR+) or triple negative (ER-/PgR-/HER2-) breast cancer. In basal-like xenografts, glycerophosphocholine (GPC) concentrations were higher than phosphocholine (PCho) concentrations, whereas this pattern was reversed in luminal-like xenografts. These differences may be explained by lower choline kinase (CHKA, CHKB) expression as well as higher PtdCho degradation mediated by higher expression of phospholipase A2 group 4A (PLA2G4A) and phospholipase B1 (PLB1) in the basal-like model. The glycine concentration was higher in the basal-like model. Although glycine could be derived from energy metabolism pathways, the gene expression data suggested a metabolic shift from PtdCho synthesis to glycine formation in basal-like xenografts. In agreement with results from the xenograft models, tissue samples from triple negative breast carcinomas had higher GPC/PCho ratio than samples from ER+/PgR+ carcinomas, suggesting that the choline metabolism in the experimental models is representative for luminal-like and basal-like human breast cancer. The differences in choline metabolite concentrations corresponded well with differences in gene expression, demonstrating distinct metabolic profiles in the xenograft models representing basal-like and luminal-like breast cancer. The same characteristics of choline metabolite profiles were also observed in patient material from ER+/PgR+ and triple-negative breast cancer, suggesting that the xenografts are relevant model systems for studies of choline metabolism in luminal-like and basal-like breast cancer.
      datePublished:2010-08-17T00:00:00Z
      dateModified:2010-08-17T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2407-10-433
      keywords:
         Breast Cancer
         Choline
         Xenograft Model
         Triple Negative Breast Cancer
         Solute Carrier Family
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-433/MediaObjects/12885_2010_Article_2232_Fig3_HTML.jpg
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Siver A Moestue
            affiliation:
                  name:Norwegian University of Science and Technology (NTNU)
                  address:
                     name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Eldrid Borgan
            affiliation:
                  name:Norwegian University of Science and Technology (NTNU)
                  address:
                     name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                     type:PostalAddress
                  type:Organization
                  name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Else M Huuse
            affiliation:
                  name:Norwegian University of Science and Technology (NTNU)
                  address:
                     name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Evita M Lindholm
            affiliation:
                  name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Beathe Sitter
            affiliation:
                  name:Norwegian University of Science and Technology (NTNU)
                  address:
                     name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anne-Lise Børresen-Dale
            affiliation:
                  name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Oslo
                  address:
                     name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olav Engebraaten
            affiliation:
                  name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Oslo
                  address:
                     name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gunhild M Mælandsmo
            affiliation:
                  name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ingrid S Gribbestad
            affiliation:
                  name:Norwegian University of Science and Technology (NTNU)
                  address:
                     name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Norwegian University of Science and Technology (NTNU)
      address:
         name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
         type:PostalAddress
      name:Norwegian University of Science and Technology (NTNU)
      address:
         name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
         type:PostalAddress
      name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:Norwegian University of Science and Technology (NTNU)
      address:
         name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
         type:PostalAddress
      name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:Norwegian University of Science and Technology (NTNU)
      address:
         name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
         type:PostalAddress
      name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:University of Oslo
      address:
         name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
         type:PostalAddress
      name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:University of Oslo
      address:
         name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
         type:PostalAddress
      name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:Norwegian University of Science and Technology (NTNU)
      address:
         name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Siver A Moestue
      affiliation:
            name:Norwegian University of Science and Technology (NTNU)
            address:
               name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Eldrid Borgan
      affiliation:
            name:Norwegian University of Science and Technology (NTNU)
            address:
               name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
               type:PostalAddress
            type:Organization
            name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Else M Huuse
      affiliation:
            name:Norwegian University of Science and Technology (NTNU)
            address:
               name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
               type:PostalAddress
            type:Organization
      name:Evita M Lindholm
      affiliation:
            name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Beathe Sitter
      affiliation:
            name:Norwegian University of Science and Technology (NTNU)
            address:
               name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
               type:PostalAddress
            type:Organization
      name:Anne-Lise Børresen-Dale
      affiliation:
            name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
            name:University of Oslo
            address:
               name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Olav Engebraaten
      affiliation:
            name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
            name:University of Oslo
            address:
               name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Gunhild M Mælandsmo
      affiliation:
            name:Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Ingrid S Gribbestad
      affiliation:
            name:Norwegian University of Science and Technology (NTNU)
            address:
               name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
      name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
      name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
      name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
      name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
      name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
      name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

External Links {🔗}(175)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.2s.